Abstract

Background. The use of antibiotics in food production selects for resistant bacteria and may cause a threat to human and animal health. Belgium and the Netherlands have one of the highest densities of broilers and pigs in Europe, making active monitoring of antibiotic use and resistance in this region vital. Objectives. This study aimed to quantify ESBL-producing (ESBL-E. coli), carbapenem- and ciprofloxacin-resistant (CiproR) Escherichia coli in animal feces on broiler and pig farms with a history of high antibiotic use in Belgium and the Netherlands. Methods. A total of 779 broiler and 817 pig fecal samples, collected from 29 conventional broiler and 31 multiplier pig farms in the cross-border region of Belgium and the Netherlands, were screened for the presence of antibiotic-resistant E. coli using selective culturing. Results. Carbapenem-resistant E. coli were not detected. ESBL-E. coli were remarkably more prevalent in samples from Belgian than Dutch farms. However, CiproR-E. coli were highly prevalent in broilers of both countries. The percentage of samples with ESBL- and CiproR-E. coli was lower in pig compared to poultry farms and varied between farms. No clear association with the on-farm antibiotic use in the year preceding sampling was observed. Multidrug resistance was frequently observed in samples from both countries, but ESBL-production in combination with ciprofloxacin resistance was higher in samples from Belgium. Conclusions. This study demonstrated marked differences in antibiotic resistance between countries, farms and within farms. The observed variation cannot be explained straightforward by prior quantity of antibiotic use suggesting that it results from more complex interactions that warrant further investigation.

Highlights

  • Pig and poultry meat is often produced in specialized and intensive livestock systems with high animal densities, large production units with application of strict biosecurity measures and use of preventive vaccinations and antibiotic treatments [1]

  • The aim of this study was to investigate the percentage of samples with extended-spectrum beta-lactamase (ESBL)-producing E. coli (ESBL-E. coli), carbapenem-resistant and ciprofloxacin-resistant E. coli (CiproR-E. coli) in Belgian and Dutch pig and poultry farms with a history of high antibiotic use

  • The total treatment incidence (TI) of beta-lactams and fluoroquinolones and active substances of these antibiotics used one year before sampling per farm are shown in Figure 1 and Supplementary Materials Tables S1 and S2

Read more

Summary

Introduction

Pig and poultry meat is often produced in specialized and intensive livestock systems with high animal densities, large production units with application of strict biosecurity measures and use of preventive vaccinations and antibiotic treatments [1]. In Escherichia coli, extended-spectrum beta-lactamase (ESBL)-production and carbapenem and fluoroquinolone resistance result in a decreased efficiency of critically important antibiotics, such as thirdand fourth-generation cephalosporins, meropenem and ciprofloxacin [6,7]. Resistance to these substances in intestinal bacteria of animals has become a threat to human health because of the potential risk of spread to humans [8]. This study aimed to quantify ESBL-producing (ESBL-E. coli), carbapenem- and ciprofloxacin-resistant (CiproR) Escherichia coli in animal feces on broiler and pig farms with a history of high antibiotic use in Belgium and the Netherlands. The observed variation cannot be explained straightforward by prior quantity of antibiotic use suggesting that it results from more complex interactions that warrant further investigation

Objectives
Methods
Results
Discussion
Conclusion
Full Text
Published version (Free)

Talk to us

Join us for a 30 min session where you can share your feedback and ask us any queries you have

Schedule a call